2024. To evaluate the Efficacy of Teneligliptin as an add-on Therapy in type 2 Diabetes Mellitus (T2DM) Patients with Inadequate Glycemic Control with a Stable dose of Metformin 1 to 2g and Glimipride 1 to 6mg Per Day . Academia Journal of Medicine. 4, 2 (Sep. 2024), 61–66. DOI:https://doi.org/10.48165/sjmv1n60.